ConductScience.org, home
ACKR3: atypical chemokine receptor 3
API referenceFor AI assistants

Gene · 57007

NIH grants2,255

NIH grants whose papers are about the gene, through NIH's grant-paper links.

61 to 80 of 2,255

Download this page as JSON
GrantTitleACKR3 papersNewest fiscal year
R01AI040098B lymphocyte Migration and Homeostasis22025
R01AR040312CD1-restricted T-cell Responses in Skin22025
R01CA172310Novel Targeted Anticancer Agents from Marine Cyanobacteria22025
R01EY011500Structure-function studies of visual arrestin22025
R01MH112205Molecular Details of Psychoactive Drug Actions22025
R01NS029709Excitability and Plasticity of Developing Epileptic Brain22025
R01NS076991Oligodendrocyte-focused rAAV gene therapy strategies for Canavan disease and Leukodystrophies22025
R28AA012725Brain Tissue Resource Center for Alcohol Research22025
R50CA221807Specialist in Multi-Scale Molecular Imaging of Tumor Environments22025
T32AG055378Neuroscience of Aging, Neurodegeneration and Alzheimer's Disease22025
T32ES007255Multidisciplinary Training in Environmental Toxicology22025
T32HL007185Multidisciplinary Training Program in Lung Disease22025
T32NS007222Training in Clinical and Basic Neuroscience22025
U19AG055373Trans-omics Integration of Multi-omics Studies for Osteoporosis22025
U54MD007600Center for Collaborative Research in Health Disparities22025
ZIABC010891Development of antibody engineering-based cancer therapies22025
ZIADK031117Development of Drugs Acting at Adenosine Receptors22025
ZIAHL002541Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)22025
ZIAHL006001Framingham Project/Levy22025
F31AG077836Elucidating the Effects of Post-Translational Modifications on Tau Binding to F-actin and PSD9512025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/57007/grants?page=4

API referenceFor AI assistants